ClinicalTrials.gg
CompletedNCT00884351Updated Jul 2, 2017

Magnetoencephalography in Absence Seizures

An observational study in Seizures, sponsored by National Institute of Neurological Disorders and Stroke (NINDS). Completed at 1 site in United States. Open to participants aged 7 Years to 35 Years. Per ClinicalTrials.gov, last updated 2017-07-02.

Sponsored by National Institute of Neurological Disorders and Stroke (NINDS) · Observational

Study type
Observational
Time perspective
Prospective
Enrollment
5
Ages
7 Years to 35 Years
Sex
All
01

Study summary

Background:

  • An absence seizure is a type of seizure that usually begins in childhood and goes away by early adulthood. Scientists do not yet know where absence seizures begin in the brain. Some evidence suggests that these seizures begin in the thalamus, a structure deep in the brain, but other studies suggest that they begin in the frontal cortex, at the front part of the brain.
  • Magnetoencephalography is a type of brain scanning procedure that is useful in determining information about what happens to the brain during epileptic seizures. Understanding where absence seizures come from may help doctors find new treatments for them.

Objectives:

  • To gain a better understanding of which parts of the brain are affected in absence seizures.

Eligibility:

  • Patients 7 to 35 years of age who have been diagnosed with absence seizures.

Design:

  • Procedures are for research purposes only, not to diagnose or treat a particular medical condition.
  • Two outpatient visits to the National Institutes of Health Clinical Center: evaluation and scanning.
  • Researchers will evaluate potential participants with a medical history, physical examination, and electroencephalography (EEG). These tests will be performed under another protocol, 01-N-0139.
  • Patients will undergo magnetoencephalography (MEG) and magnetic resonance imaging (MRI) of the brain. The study procedures will be performed one time; however, an MEG or MRI scan may need to be repeated for technical reasons. Researchers will not do more than two MEG or MRI scans.
  • The MEG will record very small magnetic field changes produced by the activity of the brain. An EEG will be recorded at the same time as the MEG.
  • The MRI will use a magnetic field to take pictures of the inside of the brain.
  • The MEG will take 3 hours to complete (2 hours for preparation, 1 hour in the scanner). The MRI will take approximately 1 hour.
Read the detailed description

Objective:

This protocol will test the hypothesis that the 3-Hz spike-wave discharges seen in absence epilepsy originate in the thalamus. We will use an emerging modality, magnetoencephalograpy (MEG), to test this hypothesis.

Study Population:

33 patients with absence seizures.

Design:

This is a non-invasive imaging study that involves a 275-channel whole head MEG recording and a structural MRI for co-registration of MEG data.

Outcome Measure:

The primary outcome measure is the source localization of spike-wave discharges on magnetoencephalography.

02

Conditions studied

  • Seizures

Keywords

  • Epilepsy
  • MEG
  • Seizures
03

In context

Seizures

896 studies on the registry are indexed under Seizures; 145 are open to participants now.

This study's enrollment of 5 is below the median of 145 across 238 observational studies indexed under Seizures.

Browse Seizures studies →

Lead sponsor

National Institute of Neurological Disorders and Stroke (NINDS) is the lead sponsor of 601 studies on the registry; 56 are open to participants now.

Of its 18 completed or terminated interventional studies of FDA-regulated products, 8 (44%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
7 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age 7-35

    1. Absence of seizures based on clinical and electroenecephalography data. Patients who have other seizure types (myoclonic, generalized tonic-clonic) in addition to absence seizures may be included.
    2. Patients who have other neurologic disorders may be included, as long as they are able to consent/assent.

Exclusion criteria

EXCLUSION CRITERIA:

  1. Contraindications to MEG studies (Dental braces, permanent retainers, metal dental caps/crowns/fillings)
  2. Contraindications to MRI studies (such as pacemakers, cochlear devices, surgical clips, metallic implants, orthopedic pins, shrapnel, permanent eyeliner, vagus nerve stimulator)
  3. Claustrophobia or anxiety disorders exacerbated by MRI
  4. Pregnancy
  5. Inability to provide consent/assent
05

Study design

Time perspective
Prospective
Enrollment
5 participants (actual)
06

Study locations

1 site
  • National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892, United States
07

References and documents

Publications

  • Avoli M, Gloor P. Role of the thalamus in generalized penicillin epilepsy: observations on decorticated cats. Exp Neurol. 1982 Aug;77(2):386-402. doi: 10.1016/0014-4886(82)90252-7. No abstract available. PubMed 7095066 ↗
  • Bernasconi A, Bernasconi N, Natsume J, Antel SB, Andermann F, Arnold DL. Magnetic resonance spectroscopy and imaging of the thalamus in idiopathic generalized epilepsy. Brain. 2003 Nov;126(Pt 11):2447-54. doi: 10.1093/brain/awg249. Epub 2003 Aug 5. PubMed 12902313 ↗
  • Castro-Alamancos MA. Neocortical synchronized oscillations induced by thalamic disinhibition in vivo. J Neurosci. 1999 Sep 15;19(18):RC27. doi: 10.1523/JNEUROSCI.19-18-j0005.1999. PubMed 10479720 ↗
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 2, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00884351
First posted
Apr 20, 2009
Start date
Apr 15, 2009
Completion
Jun 15, 2011
Last update
Jul 2, 2017
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion